GlobalData on MSN9d
FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini BThe latest authorised panel targets bacterial infections, including Campylobacter, Shigella, Yersinia enterocolitica, and ...
9d
Zacks Investment Research on MSNQGEN Stock Up on FDA Nod for Second QIAstat-Dx Gastrointestinal PanelQIAGEN N.V. QGEN has secured FDA clearance for its QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, bolstering its syndromic testing portfolio in the United States. This marks the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results